Register now
  • 00Days to go

Partnership Opportunities

The 15th Asia-Oceania ORL-HNS Congress 2023 theme is “Reaching Out – Maximising regional cooperation and resources to advance patient care”, and with expectations of 1,200 attendees, we hope that this congress will creating a lasting legacy for excellence in surgery and collaboration in the field of Otolaryngology Head and Neck Surgery for the region.

Principal partners

Major partners

Industry Program partners

Supporting partners

Exhibitors

Educational partners

Royal Australian College of Surgeons Logo

Workshop partners

Congress Co-Hosts

Exhibitors

Reasons to be involved:

Strengthen your brand in the market

Aligning your company with this powerful educational and international experience demonstrates your commitment to assisting professional development and further strengthens your brand within the market.

Heightened Visibility

You will have significant exposure prior to the congress through the website and marketing materials. There is no better way to position your organisation to up to 1,200 surgeons, otolaryngologists and allied health professionals from around the world.

Stand out from the crowd

Create your competitor difference by producing a unique and dynamic presence at the congress exhibiting.

Create your competitor difference by producing a unique and dynamic presence at the congress exhibiting.

Have you missed getting together in a room to talk in-person? This congress will give you limitless opportunities to meet and move forward with your business partners.

Network in an educational and social environment

Networking develops quality business relationships by having direct one to one engagement in a relaxed environment. Meet at one of our many social events or in the exhibition from across the globe.

Partner Prospectus

Partnership Prospectus

View Prospectus Here

BCEC's Floorplan

View Floor Plan

Applications for partnership and exhibition space are now open

For all partnership or exhibition enquiries, please contact our congress secretariat and industry liaison

Thomas Howden
Partnership Director

Organiser

MCI Australia
Level 11, 87 Wickham Terrace
Spring Hill  QLD  4000

+61 7 3858 5400

support@orlhns23.com

Quicklinks

Stay in Touch

Join mailing list
Facebook Twitter

© 2023 ORL-HNS 2023. All Rights Reserved.

MCI-Flower-White.png

Designed and built by MCI Australia

Medtronic ENT

Medtronic ENT providing solutions for over 20 years for Ear (Otological) Nose (Rhinology) and Throat (Laryngology/Head & Neck Cancer) Conditions. Treating patients with Chronic ENT conditions from Otological or Hearing disruption due to infection, congenital conditions, and trauma. Rhinology for Chronic Rhinosinusitis and upper nasal airway obstruction due to sinus disease pathology. Tracheal airway conditions that obstruct laryngeal structures including tracheal papilloma to Thyroidectomy and Head & Neck cancer conditions. We look forward to partnering with you.

3D Matrix

Since the inceptions of 3-D Matrix as a spinoff from MIT in 2004, 3-D Matrix has grown to become leading global peptide solutions company headquartered in Tokyo, Japan. With offices serving the Americas, Europe and Asia our employees together with our partners and distributor serve research scientists, healthcare providers and patients around the globe.

Due to the highly vascular nature of nasal tissue, post-operative haemostasis has always been a concern. The use of tamponade through the insertion of nasal packing is still commonly used but may be at the expense of patient comfort. Excessive pressure caused by tamponade may also be detrimental to the outcomes of delicately performed sinus surgery.

PuraStat® is a slightly viscous solution of RADA16 synthetic peptides. Contact between PuraStat® and blood causes the peptide solution to be neutralized and exposed to ions, resulting in the formation of ß-sheets that then form a 3-dimensional scaffold structure that is instantaneous, causing a physical (mechanical) closing of the superficial part of the broken blood vessel, resulting in haemostasis (induces natural blood coagulation).

GlaxoSmithKline (GSK)

GSK is now a fully focussed biopharma company with a new purpose: to unite science, technology and talent to get ahead of disease together. As our experts seek innovative new ways to treat the human body, specialty medicines are at the forefront of our high-value pipeline of new products. We have leading global positions in developing medicines for respiratory disease and HIV, and we are building our presence in other key therapy areas such as oncology and immunology.

Sanofi

Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders.

Cochlear

Cochlear is the global leader in implantable hearing solutions, bringing sound to people with moderate to profound hearing loss. We aim to give our recipients the best lifelong hearing experience and access to innovative future technologies. For our professional partners, we offer the industry’s largest clinical, research and support networks.

Advanced Bionics

Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world.  Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best.  AB offers the most sophisticated cochlear implant systems on the market, the HiResolutionTM Bionic Ear System, with five times more sound resolution than its competitors.

Ambu

Ambu is an innovative medical device company specialising in single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. Headquartered in Denmark, Ambu employs 4,500+ people globally with an ANZ head office in Sydney. In 2009 Ambu invented the world’s first single-use flexible endoscope and today offers a convenient solution across ENT, Bronchoscopy, Cystoscopy and GI.

FESS (Care Pharmaceuticals)

CARE Pharmaceuticals was established in Australia in 1986 to provide innovative over the counter products for all members of the family. Now a Prestige Brands company, our trusted brands include FESS®, Hydralyte®, Murine®, Little® and Lacto-Free®, which are synonymous with quality, safety and efficacy

Chitogel

Chitogel is a global medical device company, offering a leading-edge wound healing gel for use in endoscopic sinus surgeries. The Chitogel Endoscopic Sinus Surgery Kit has been successful across global markets, including the U.S., New Zealand and Australia.

Optimising wound healing after sinus surgery is critical to achieving long term, positive patient outcomes. Chitogel is a clinically proven hydrogel that is designed to support rapid wound healing, minimise adhesions, preserve structural integrity and address patient comfort.

ControMed Pty Ltd

Contromed Pty Ltd is an Australian based Medical Distribution Company, specialising in the Sales and Marketing of ENT products Nationally.

CoreMed Pty Ltd.

CoreMed is an Australian based medical distribution company, specialising in the field of ENT. CoreMed is the exclusive distributor for Spiggle & Theis, a world-renowned medical device manufacturer specialising in ENT instruments and consumables. We are also the Australian Distributors for inomed for ENT/Thyroid Nerve Monitoring.

CSL Seqirus

ON THE FRONT LINE OF PUBLIC HEALTH PROTECTION

CSL Seqirus has public health protection at its core, reflecting the promise of our parent company – CSL Limited – which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many people around the world. CSL Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccines and produces a range of specialised medicines in the national interest, including antivenoms and Q fever vaccines. CSL Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products including Ryaltris® (Olopatadine hydrochloride & Mometasone furoate monohydrate) Nasal Spray, Acarizax® (American house dust mite extract & European house dust mite extract) Sublingual Tablets and Grazax® (Phelum pretense) Sublingual Tablets.

 

RYALTRIS® is a registered trade mark of Glenmark Specialty S.A. ACARIZAX® & GRAZAX® are registered trademarks of ALK-Abelló A/S, used under licence. Seqirus™ is a trademark of Seqirus UK Limited or its affiliates. ABN 66 120 398 067. Seqirus (Australia) Pty Ltd, Melbourne, Australia. www.seqirus.com.au Medical Information: 1800 642 865.

Customised Compounding

Customised Compounding specialises in customising medications to suit individual needs. Our pharmacists have over 100 years of pharmacy experience. Our facility  NATA/ISO certified, has state-of-the art compounding equipment and uses only USP or BP grade ingredients to compound both non-sterile and sterile preparations to suit both doctor and patient’s needs. 

ECO Medical

Established its headquarter in Nanjing in 2000, ECO Medical is a medical equipment manufacture dedicated to R & D, manufacturing and marketing activities of microwave ablation, high-frequency & laser products. Saberwave ECO-200G, a 2.45GHz water cooling microwave ablation system is the latest generator with CE & FDA approval.

 

 

Endotherapeutics

Endotherapeutics was founded in 1999 with a small team, and a number of innovative, niche medical technologies that provided quality of life improving solutions to healthcare professionals.

Over 20 years of experience has allowed Endotherapeutics to develop extensive knowledge of the Australian and New Zealand healthcare systems. This includes the registration and reimbursement of new medical technologies, and their successful sales and marketing.

ENT Technologies Pty Ltd

ENT Technologies Pty Ltd, specialises in the formulation, development and delivery of novel pharmaceutical preparations for the management of both acute and chronic pathologies of both nasal and sinus cavities. Activities are now expanding to novel therapies for the treatment of Laryngopharyngeal Reflux and other laryngeal pathologies.

The company has recently been purchased by Aspen Pharmacare Australia and will experience an increased presence in upper airway disease management as significant funding is now being allocated to research projects.

Getz Healthcare

Pioneers in global distribution for over 110 years, Getz Healthcare is the destination of choice for the medical industry, connecting communities with the latest and most advanced equipment, products, and services from around the world.

With unmatched expertise and comprehensive knowledge of the medical device industry, we pride ourselves on our ability to forecast and understand future demands to offer our customers a competitive edge based on predicting what patients want and what medical care providers need.

With a full suite of end-to-end services, Getz Healthcare offers extensive support for hospitals, specialist clinics, and healthcare providers, ensuring they are equipped with new techniques and the latest innovations to better care for their patients. 

With specialised access to a range of companies, led by research insights and leading experts, our business partners trust us to make well founded decisions, ensuring that not only who we partner with is reliable but is also the best the global market has to offer. 

JULLSURG

We, JULLSURG are the Manufacturer of ENT Surgical Instruments . JULLSURG Established in 1948, we have a long –standing global reputation for quality, excellence and outstanding service. Our instruments are well known for their high quality, durability and performance.

JULLSURG instruments certified with ISO, CE mark and US FDA registered.

JULLSURG Instruments can be purchase online @ www.jullsurgonline.com 

Karl Storz Endoscopy Australia

Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices. We are no giant on an international scale but a leader in the things that matter: creativity, flexibility, and expertise.

From basic equipment for the ENT practice and outpatient settings to complete sets of endoscopic and surgical instruments through to the high-technology system for video-assisted endoscopy, the medical practitioner receives everything from one source: Perfectly matched endoscopes, instruments and units in excellent quality. 

Visit the KARL STORZ website www.karlstorz.com to find out more about the complete KARL STORZ range.

 

Lateral Medical

Lateral Medical is an Australian-owned company that specialises in providing medical professionals with innovative and cost effective medical supplies that improve patient care and clinical outcomes. We are focused on the areas of Anaesthetics & Critical Care, ENT, Infection Control & OH&S, Orthopaedics & Positioning, Obstetrics & Gynaecology and Surgical & Airway Suction. Lateral Medical has a local network of sales, support, education & distribution throughout Australia & New Zealand.

LSR Healthcare

LSR Healthcare Pty Ltd has 50 years of combined experience in clinical and commercial healthcare.


Over the years we have expanded our product lines, thereby increasing the number of medical professionals we serve across Australia and New Zealand whilst still providing attentive service to the healthcare industry.

MED-EL

MED-EL offers the widest range of implantable and non-implantable solutions to treat all degrees of hearing loss across 124 countries and more than 4000 clinics worldwide. Our hearing solutions include cochlear and middle ear implant systems, a system for electric acoustic stimulation, implantable and surgery-free bone conductors, and brainstem implants.

Medical Devices Pty Ltd

Medical Devices Pty Ltd is an independent Australian company established in 1991 and operating in all states and territories. We are committed to the supply and support of high quality medical equipment managed by our quality system certified under ISO 9001. As our product range has grown over the last 20 years, we have developed specialized skills and equipment to better service, Specialist Procedure Centres and  key hospital departments of Operating Suite, Intensive Care, Emergency and Radiology.

Mi-Tec Medical Publishing

Mi-tec Medical Publishing produces high-quality and peer-reviewed patient education publications for the Australian Society of Otolaryngology Head and Neck Surgery and the Royal Australasian College of Surgeons, as well as 20 other medical colleges, societies and associations in Australia and New Zealand. 

The objective of the publications is to reduce the medico-legal risk of “failure to inform” by assisting the informed consent process. Our patient education pamphlets have been written, edited, peer reviewed and published entirely in Australia and New Zealand for over 30 years.

NSE

NSE is in the leading position in the field of innovative medical lighting, medical HD imaging and sleep health. It has a number of product lines with distinct characteristics and strong market competitiveness, and has formed a complete research & development, production system and worldwide marketing service network.

Oticon Medical

Because sound matters

Oticon Medical is a global company in bone anchored and cochlear implant hearing solutions – dedicated to bringing the power of sound to people at every stage of life. As part of the Demant group, a global leader in hearing healthcare, we have access to one of the world’s strongest research and development team, the latest technological advances, and insights into hearing care.

info@oticonmedical.com.au

Otopront

Otopront is a family-owned medical equipment manufacturer in Germany, selling high-quality ENT equipment for more than 70 years. Otopront is represented in more than 150 countries with a reliable sales and service network. Our product portfolio ranges from Treatment and Diagnostic units with Chairs to Video Endoscopy systems and Otoacoustic Diagnostic. 

The Royal Australasian College of Surgeons (RACS)

RACS is the leading advocate for surgical standards, professionalism and surgical education in Australia and New Zealand. The College is a not-for-profit organisation that represents more than 7,000 surgeons and 1,300 surgical trainees and International Medical Graduates.

The College provides continuous professional development, training and accreditation for surgeons. There are nine surgical specialties in Australasia being: Cardiothoracic surgery, General surgery, Neurosurgery, Orthopaedic surgery, Otolaryngology Head-and-Neck surgery, Paediatric surgery, Plastic and Reconstructive surgery, Urology and Vascular surgery.

RhinoSurgical | KURZ

Rhino Surgical Australia Pty Ltd is a new generation healthcare company. We are a leading provider of evidence-based technologies for ENT specialties. We are proud to provide a significant and sustainable impact on healthcare by delivering technologies that enhance clinical care and satisfy the growing economic needs of our customers.

Samson Medical Technologies

Samson Medical Technologies was established in 2015 with a vision to provide innovative, clinically proven biotech, medical and cosmetic technologies to the Australian and New Zealand markets. Headquartered in Sydney with on the ground presence and support in all states and territories. We have key relationships with leading manufacturers both in ANZ and globally. This allows Samson to be at the forefront of new product developments, global trends and treatments in demand. We work with some of the brightest and most skilled individuals in our society. Our purpose is simply to augment these skills using our technologies to provide improved patient outcomes.

SomnoMed

SomnoMed, founded in 2004, leads the world in the development of devices for Obstructive Sleep Apnea and provides clinicians an effective alternative to CPAP for their patient. We understand OSA is a chronic disease with a burden on patients and strive to continuously design solutions to improve efficacy and compliance. Innovation has always centred on the device, the materials used and a customised comfortable fit.

Stark Medical Pty Ltd

Stark Medical is an Australian owned distributor for specialty products including high quality equipment from ATMOS including Microscopes, Patient Chairs, Suction Pumps and Workstations, Instruments from NOPA and consumables from Sheffmed. 

Stallergenes Greer

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services. Established in 2015, Stallergenes Greer combines a hundred years of allergy expertise of Greer in the United States with Stallergenes’ history of innovation in allergy immunotherapy (AIT or desensitisation) from a base in France.

Our purpose is to enable precision medicine to improve life for people with allergies. As part of our commitment to help patients live life beyond allergy, we offer the broadest portfolio of allergen extracts on the market, a wide range of state-of-the-art therapeutic solutions for children and adults, as well as for veterinary purposes. Spanning source materials, routes of administration, cutting-edge delivery mechanisms and finished products, ours is an innovative portfolio of therapeutic solutions designed to improve ease of access and treatment outcomes.

To contact Stallergenes Greer, email allergyaustralia@stallergenesgreer.com. For medical information enquiries, contact Dr. Martin Rees martin.rees@stallergenesgreer.com

Stryker

Transforming healthcare is at the heart of what we do. We do this by collaborating with our customers to develop innovative products and services that ultimately improves the lives of our patients. Our commitment is expressed clearly through our mission: Together with our customers, we are driven to make healthcare better.

Tristel

Tristel is the global leader in chlorine dioxide disinfectant solutions for medical devices and healthcare surfaces. Its lead technology has been a ground-breaking innovation in the world of Infection Prevention. Tristel has been providing hospitals around the world with the safest, fastest and smartest disinfectant solutions for over two decades.

Vorotek

VorOtek was founded in 1971 by Australian ENT surgeon Dr John Vorrath. For over fifty years Dr Vorrath and VorOtek have been developing and manufacturing fully integrated optical systems with illumination.  The aim has always been to provide users with products which enhance their capability for examination, instrumentation and procedures

World Intra-Operative Neuromonitoring

World Intra-operative Neuromonitoring is a boutique company that specializes in customizing a multi-modality monitoring plan for the patient and surgeon to provide a better surgical outcome. At a moment’s notice we provide IONM service, education, consult, or (remote) with a full custom modality set-up including MEP, SSEP, EMG, EEG and tEMG to provide comprehensive coverage.

Carl Zeiss Pty Ltd

The Carl Zeiss Group is a leading group of companies operating worldwide in the optical and opto-electronic industries.

We hope to see you at the ZEISS booth during the 15th Asia Oceania ORL-HNS Congress so that you may experience the TIVATO 700 and EXTARO 300 surgical microscopes. These microscopes allow otolaryngology and head & neck surgeons to fulfil their clear need for premium optical performance in the operating theatre. 

Prof Sarah Wise

Emory University School of Medicine

Sarah K. Wise, MD, MSCR is Professor of Otolaryngology-Head and Neck Surgery at Emory University in Atlanta, Georgia. She is the Emory Otolaryngology Residency Program Director, Rhinology Fellowship Director, and Director of Otolaryngic Allergy. Dr. Wise completed medical school at the University of Texas Health Science Center San Antonio, residency at Emory University and rhinology fellowship at the Medical University of South Carolina. Dr. Wise has served on the Board of Directors of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. She will become President of the American Rhinologic Society in September 2022, serving as the Society’s first female president. Her clinical interests include inflammatory rhinology, otolaryngic allergy, relationship of allergy and chronic rhinosinusitis, and cerebrospinal fluid leaks. Dr. Wise lectures nationally and internationally. Her most notable publication is the International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis, where she served as first author/primary editor.

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.